中国实用外科杂志
• 专题笔谈 • 上一篇 下一篇
陈 曦,陈海珍
出版日期:
发布日期:
Online:
Published:
摘要:
术后甲状旁腺功能减退(甲旁减)药物治疗的主要目标是维持机体钙稳态、改善病人整体状况。急性低钙血症时,以静脉补钙、维持血电解质平衡、控制症状体征为主。长期治疗的标准方案是口服钙剂和活性维生素D,必要时辅以噻嗪类利尿剂,以维持血钙正常低限,并避免高尿钙、肾结石、异位钙化等并发症发生。重组人甲状旁腺激素(PTH)用于传统治疗无法良好控制血钙的病人,新型小分子PTH受体1(PTHR1)激动剂等药物仍在研发中。
关键词: 甲状旁腺功能减退, 药物治疗
Abstract:
Drug therapy of postoperative hypoparathyroidism CHEN Xi, CHEN Hai-zhen. Department of General Surgery, Ruijin Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai 200025, China Corresponding author:CHEN Xi, E-mail:cx10774@rjh.com.cn Abstract Calcium homeostasis is aimed in management of postsurgical hypoparathyroidism.When acute hypocalcemia need urgent treatment,iv calcium therapy is used to control symptoms,reverse signs and restore the serum calcium level to the lower end of the normal range. Standard long-term protocol of chronic hypoparathyroidism is oral calcium and active vitamin D supplementation,with thiazide diuretics if necessary,to maintain serum calcium in low normal reference and asymptomatic ranges,and to reduce the risk of complications,such as hypercalciuria,kidney stones,and ectopic calcification.Recombinant human PTH is only recommended for patients who cannot be well-controlled by conventional regimens.Orally active small-molecule PTHR1 agonist is in preclinical studies.
Key words: hypoparathyroidism, drug therapy
陈 曦,陈海珍. 甲状腺术后甲状旁腺功能减退的药物治疗[J]. 中国实用外科杂志, DOI: 10.19538/j.cjps.issn1005-2208.2018.06.08.
0 / 推荐
导出引用管理器 EndNote|Ris|BibTeX
链接本文: https://www.zgsyz.com/zgsywk/CN/10.19538/j.cjps.issn1005-2208.2018.06.08
https://www.zgsyz.com/zgsywk/CN/Y2018/V38/I06/619